Pharmacokinetics of Midazolam and 1′-Hydroxymidazolam in Chinese with Different CYP3A5 Genotypes
- 1 December 2002
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 30 (12) , 1491-1496
- https://doi.org/10.1124/dmd.30.12.1491
Abstract
The CYP3A subfamily represents the most abundant cytochrome P450 in the human liver and gastrointestinal tract and plays very important role in xenobiotic metabolism. CYP3A5 is expressed in a relatively small population of whites and Orientals. We recruited 42 Chinese volunteers to determine the genotypes of CYP3A5 by polymerase chain reaction-restriction fragment length polymorphism. Genotype analyses revealed thatCYP3A5*3 allele existed in 39 of 42 volunteers.CYP3A5*4 and CYP3A5*5 alleles were found in one volunteer each; and CYP3A5*2 andCYP3A5*6 alleles were not found. The most frequentCYP3A5*3 allele is known not to express CYP3A5. We excluded other genotypes of CYP3A5 to study the significance of CYP3A5*3 in midazolam pharmacokinetics. In this study, each volunteer was given a midazolam tablet (7.5 mg) orally. Blood samples were collected to analyze the time-dependent concentrations of midazolam and 1′-hydroxymidazolam by high-performance liquid chromatography. The average area under plasma concentration curve (AUC, 0–8 h) of midazolam was 9237 ± 1050 ng-min/ml (mean ± S.E.M.) in homozygous CYP3A5*3(n = 14) subjects and 7934 ± 768 ng-min/ml in heterozygous CYP3A5*1/*3 (n = 12) subjects, respectively. The average AUC (0–8 h) of 1′-hydroxymidazolam was 3748 ± 427 ng-min/ml in homozygous CYP3A5*3subjects and 3920 ± 402 ng-min/ml in heterozygousCYP3A5*1/*3 subjects. The results indicated that the pharmacokinetics of midazolam and 1′-hydroxymidazolam was independent of CYP3A5 expression. Although the genetic polymorphism of CYP3A5 is well known, the results of this study suggested that the clinical consequence might be insignificant.This publication has 27 references indexed in Scilit:
- Intergenic mRNA Molecules Resulting fromtrans-SplicingJournal of Biological Chemistry, 2002
- Cloning and Tissue Distribution of a Novel Human Cytochrome P450 of the CYP3A Subfamily, CYP3A43Biochemical and Biophysical Research Communications, 2001
- Dissecting the function of cytochrome P450Published by Wiley ,1996
- Detection of a CYP3A5 Allelic Variant: A Candidate for the Polymorphic Expression of the Protein?Biochemical and Biophysical Research Communications, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Substrates of human hepatic cytochrome P450 3A4Toxicology, 1995
- Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamilyBiochemical Pharmacology, 1994
- Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liverPharmacogenetics, 1994
- Gene structure of CYP3A4, an adult‐specific form of cytochrome P450 in human livers, and its transcriptional controlEuropean Journal of Biochemistry, 1993
- Expression of cytochrome P450 3A in amphibian, rat, and human kidneyArchives of Biochemistry and Biophysics, 1992